Moreover, a study has shed light on that HADH, encoding a key enzyme in fatty acid beta-oxidation, may improve prognosis of ccRCC patients by reducing infiltration of Treg cells [27]. This evidence concerns the gene HADH and nonpapillary renal cell carcinoma.